Clinical Trial Update: Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect [Phase 2, Phase 3]

View source ↗

Summary

This document describes an ongoing Phase 2/Phase 3 clinical trial evaluating minimally invasive transthoracic device closure for perimembranous ventricular sept…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perimembranous Ventricular Septal Defect

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Perimembranous Ventricular Septal Defect | Phase 2, Phase 3 | Status: UNKNOWN